aacrjournals.orgAmerican Association for Cancer Research

Skip to main content AACR Publications Blood Cancer Discovery Cancer Discovery Cancer Epidemiology, Biomarkers & Prevention Cancer Immunology Research Cancer Prevention Research Cancer Research Clinical Cancer Research Molecular Cancer Research Molecular Cancer Therapeutics Log in My Cart Advertisement Main menu Home About Us AACR Journals Subscriptions Permissions & Reprints Advertising Article Collections Focus Sections Journal Collections Hot Topics "Best of" Collection Editors' Picks For Authors Information for Authors Author Services Best of: Author Profiles Researchers Behind the Journals: Researcher Profiles Alerts Table of Contents Editors' Picks AACR Publications Blood Cancer Discovery Cancer Discovery Cancer Epidemiology, Biomarkers & Prevention Cancer Immunology Research Cancer Prevention Research Cancer Research Clinical Cancer Research Molecular Cancer Research Molecular Cancer Therapeutics User menu Log in My Cart Search Search for this keyword Advanced search Search for this keyword Advanced Search Home About Us AACR Journals Subscriptions Permissions & Reprints Advertising Article Collections Focus Sections Journal Collections Hot Topics "Best of" Collection Editors' Picks For Authors Information for Authors Author Services Best of: Author Profiles Researchers Behind the Journals: Researcher Profiles Alerts Table of Contents Editors' Picks Visit AACR on Facebook Follow AACR on Twitter Visit AACR on LinkedIn Visit AACR on YouTube In the Spotlight CONTENT END TEMPLATE -- Read more about Roisin M. Connolly , senior editor for Clinical Cancer Research , in the latest Researchers Behind the Journals profile. Read Blood Cancer Discovery 's latest article, “ Monosomic Loss of MIR15A/MIR16-1 Is a Driver of Multiple Myeloma Proliferation and Disease Progression ” by Dr. Marta Chesi and colleagues, which is now freely available online. Read this interview with Olufunmilayo Olopade , MD, of the University of Chicago Medicine, on genomics and breast cancer. Dr. Olopade will delve further into her work at the (AACR) Annual Meeting 2020 . Keep up with “what’s new” by following the AACR Journals on Twitter: @BCD_AACR : Blood Cancer Discovery @CD_AACR : Cancer Discovery @CEBP_AACR : Cancer Epidemiology, Biomarkers & Prevention @CIR_AACR : Cancer Immunology Research @CAPR_AACR : Cancer Prevention Research @CR_AACR : Cancer Research @CCR_AACR : Clinical Cancer Research @MCR_AACR : Molecular Cancer Research @MCT_AACR : Molecular Cancer Therapeutics Learn More About the AACR's Journals: Blood Cancer Discovery will provide a critical outlet for high-impact basic, translational, and clinical research on all disease subtypes of leukemia, lymphoma, myeloma, and associated diseases. Studies published in Blood Cancer Discovery will describe mechanisms underlying disease biology; diagnostic and therapeutic development; and translation of these data into clinical trials. Cancer Discovery publishes high-impact articles featuring major advances in research and clinical trials. Topics span the spectrum of cancer research and medicine from the laboratory to the clinic to epidemiologic studies. The journal also publishes News and Research Watch sections. Cancer Epidemiology, Biomarkers & Prevention publishes articles featuring population-based research on cancer etiology, prevention, surveillance, survivorship, and cancer health disparities—with a particular focus on articles with a transdisciplinary approach. Cancer Immunology Research publishes outstanding original articles reporting major advances in cancer immunology that span the discipline from basic investigations in host-tumor interactions to developmental therapeutics in model systems, early translational studies in patients, and late-stage clinical trials. Cancer Prevention Research publishes articles that focus on cancer prevention, preclinical, clinical, and translational research, with special attention given to molecular discoveries and an emphasis on building a translational bridge between the basic and clinical sciences. Cancer Research publishes original studies, reviews, and opinion pieces offering significance and broad impact to a diverse audience. Cancer Research seeks manuscripts that offer pathobiological and translational impact to inform the personal, clinical, and societal problems posed by cancer. The main scope of the journal is captured in its primary subsections: Genome and Epigenome, Metabolism and Chemical Biology, Molecular Cell Biology, Tumor Biology and Immunology, Translational Science, Convergence and Technologies, and Population and Prevention Science. Clinical Cancer Research publishes articles that focus on innovative clinical and translational research bridging the laboratory and the clinic. Topics include targeted therapies; mechanisms of drug sensitivity and resistance; pharmacogenetics and pharmacogenomics; personalized medicine; immunotherapy; gene therapy; diagnostic biomarkers; innovative imaging, and clinical genetics. Molecular Cancer Research publishes articles featuring novel, basic cancer research discoveries that prioritize broad molecular and cellular processes. Areas of emphasis include cell cycle and senescence; cell death and survival; chromatin, gene and RNA regulation; DNA damage and repair; genomics; oncogenes and tumor suppressors; and signal transduction. Molecular Cancer Therapeutics publishes articles on the discovery and preclinical development of novel therapeutic agents for oncology, preclinical studies of approved therapeutics, mechanisms of drug action, mechanism of drug resistance, biomarkers of drug response, novel models and technologies, and occasional drug toxicity mechanisms. Advertisement Back to top Home Alerts Privacy Policy Facebook Twitter LinkedIn YouTube RSS Article Collections Focus Selections "Best of" Collection Info for: Authors Subscribers Advertisers Librarians AACR Journals About AACR Journals 3rd Party Permissions & Reprints Copyright © 2020 by the ....